| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adult pneumococcal vaccination: a review of physician and patient barriers
|
Mieczkowski, Tammy A
|
|
2002
|
20 |
9-10 |
p. 1383-1392
10 p.
|
article
|
| 2 |
Anthrax vaccine efficacy in golden Syrian hamsters
|
Fellows, P.F
|
|
2002
|
20 |
9-10 |
p. 1421-1424
4 p.
|
article
|
| 3 |
Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans
|
Pittman, Phillip R
|
|
2002
|
20 |
9-10 |
p. 1412-1420
9 p.
|
article
|
| 4 |
Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination
|
Sun, Xiangle
|
|
2002
|
20 |
9-10 |
p. 1466-1474
9 p.
|
article
|
| 5 |
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy
|
Beyer, W.E.P
|
|
2002
|
20 |
9-10 |
p. 1340-1353
14 p.
|
article
|
| 6 |
Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome
|
Gampfer, Jörg
|
|
2002
|
20 |
9-10 |
p. 1354-1364
11 p.
|
article
|
| 7 |
Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model
|
Watanabe, Mineo
|
|
2002
|
20 |
9-10 |
p. 1429-1434
6 p.
|
article
|
| 8 |
Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor
|
Follador, Ivonise
|
|
2002
|
20 |
9-10 |
p. 1365-1368
4 p.
|
article
|
| 9 |
Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein
|
Wierzbicki, Andrzej
|
|
2002
|
20 |
9-10 |
p. 1295-1307
13 p.
|
article
|
| 10 |
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E
|
Hasan, U.A.
|
|
2002
|
20 |
9-10 |
p. 1308-1315
8 p.
|
article
|
| 11 |
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences
|
Ghosh, Mrinal K.
|
|
2002
|
20 |
9-10 |
p. 1369-1377
9 p.
|
article
|
| 12 |
Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD
|
Gogev, Sacha
|
|
2002
|
20 |
9-10 |
p. 1451-1465
15 p.
|
article
|
| 13 |
Long-term influence of lipid nutrition on the induction of CD8+ responses to viral or bacterial antigens
|
Bassaganya-Riera, J
|
|
2002
|
20 |
9-10 |
p. 1435-1444
10 p.
|
article
|
| 14 |
Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus
|
Golding, Basil
|
|
2002
|
20 |
9-10 |
p. 1445-1450
6 p.
|
article
|
| 15 |
New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones
|
Begum, Nurjahan
|
|
2002
|
20 |
9-10 |
p. 1281-1289
9 p.
|
article
|
| 16 |
[No title]
|
Spier, R.E
|
|
2002
|
20 |
9-10 |
p. 1259-1260
2 p.
|
article
|
| 17 |
Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes
|
Rodrı́guez, Luis Eduardo
|
|
2002
|
20 |
9-10 |
p. 1331-1339
9 p.
|
article
|
| 18 |
The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma
|
Singh, Gita
|
|
2002
|
20 |
9-10 |
p. 1400-1411
12 p.
|
article
|
| 19 |
The HIV/AIDS vaccine researchers’ orientation to the process of preparing a US FDA application for an investigational new drug (IND): what it is all about and how you start by preparing for your pre-IND meeting
|
Shapiro, Stuart Z
|
|
2002
|
20 |
9-10 |
p. 1261-1280
20 p.
|
article
|
| 20 |
The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales
|
Edmunds, W.John
|
|
2002
|
20 |
9-10 |
p. 1316-1330
15 p.
|
article
|
| 21 |
Thermostabilization of egg grown influenza viruses
|
Ikizler, Mine R
|
|
2002
|
20 |
9-10 |
p. 1393-1399
7 p.
|
article
|
| 22 |
Thirty-five years’ experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity
|
Njamkepo, E
|
|
2002
|
20 |
9-10 |
p. 1290-1294
5 p.
|
article
|
| 23 |
Time-resolved fluorometric immunoassay for rubella antibody—a useful method for serosurveillance studies
|
Christopher Maple, P.A
|
|
2002
|
20 |
9-10 |
p. 1378-1382
5 p.
|
article
|
| 24 |
Varicella seroprevalence in a random sample of the Turkish population
|
Kanra, G
|
|
2002
|
20 |
9-10 |
p. 1425-1428
4 p.
|
article
|
Journal description